===================== Product Identification =====================
MSDS NAME:51860 FLAVORED COLESTID GRANULES
NIIN:00F038085
MSDS Number: BWKPF
=== Responsible Party ===
Company:UPJOHN CO THE
Address:7171 PORTAGE RD
City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Info Phone Num:616-385-7358(D)/616-323-5122(24 HR)
Emergency Phone Num:616-323-7555(D)/616-323-5122(24 HR)
CAGE:GO374
=== Contractor Identification ===
Company:PHARMACIA & UPJOHN
Address:7171 PORTAGE RD
Box:City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Phone:616-833-5122/616-833-7555
CAGE:93703
Company:UPJOHN CO THE
Address:7171 PORTAGE RD
City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Phone:616-323-7555
CAGE:GO374
============= Composition/Information on Ingredients =============
Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
Fraction by Wt: 33%
Name:NON HAZARDOUS INGREDIENTS
Fraction by Wt: <1%
Name:COLESTIPOL HYDROCHLORIDE *94-4*
CAS:37296-80-3
RTECS #:GH1140000
Fraction by Wt: 66%
===================== Hazards Identification =====================
LD50 LC50 Mixture:ORAL LD50(RAT): >1000 MG/KG
Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYES: OCULAR EXPOSURE MAY CAUSE SEVERE
IRRITATION & CORNEAL ABRASION. INGESTION: ADVERSE REACTIONS
FOLLOWED BY OVEREXPOSURE TO GI TRACT. SKIN: DERMATITIS & SOME
MODERATE MUSCULOSKELETAL & NEUROLOGIC S IGNS.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION, CONSTIPATION, ABDOMINAL DISCOMFORT,
NAUSEA, VOMITING, DIARRHEA, WHEEZING, ASTHMA, HYPERSENSITIVITY,
URTICARIA.
Medical Cond Aggravated by Exposure:EXPOSURE TO THIS DRUG IS
CONTRAINDICATED IN PEOPLE W/KNOWN HYPERSENSITIVITY TO COLESTIPOL
HYDROCHLORIDE/HYPOTHYROIDISM/DIABETES MELLITUS/NEPHROTIC
SYNDROME/DYSPROTEINEMIAS & OBSTRUCTIVE LIVER DISEASE.
======================= First Aid Measures =======================
Eyes: FLUSH W/WATER FOR 15 MINS. SKIN: WASH W/SOAP & WATER.
INHALATION: REMOVE TO FRESH AIR. OBTAIN MEDICAL ATTENTION IN ALL
CASES. NOTE TO PHYSICIAN: OVEREXPOSURE TO THIS PRODUCT MAY
PRODUCE/WORSEN P RE-EXISTING CONSTIPATION/MAY ALTER EFFECTS OF THE
FOLLOWING DRUGS:
PROPRANOLOL/CHLOROTHIAZIDE/TETRACYCLINE/FUROSEMIDE/PENICILLIN
G/GEMFIBROZIL/DIGITALIS PREPARATIONS & ORAL PHOSPHATE SUPPLEMENTS.
===================== Fire Fighting Measures =====================
Flash Point:NONFLAMMABLE
Extinguishing Media:WATER, CO2, DRY CHEMICAL
Fire Fighting Procedures:WEAR SCBA & FULL BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:NONE
================== Accidental Release Measures ==================
Spill Release Procedures:PROVIDE VENTILATION & PERSONAL PROTECTION TO
PREVENT OVEREXPOSURE. KEEP PRODUCT OUT OF DRAINS; PREVENT ENTRY TO
SURFACE WATER. GROUNDWATER & SOIL. SMALL: ABSORBED W/PAPER
TOWEL/OTHER APPROPRIATE MEDIA L. LARGE: VACUUM/SCOOP UP & PLACED IN
CONTAINER.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE IN A COOL, DRY PLACE & PROTECT
FROM LIGHT.
Other Precautions:AVOID CONTACT W/SKIN, EYES & CLOTHING. KEEP OUT OF
REACH OF CHILDREN.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NOT REQUIRED.
Ventilation:LOCAL EXHAUST
Protective Gloves:NOT REQUIRED
Eye Protection:NOT REQUIRED
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
USE: HUMAN DRUG USED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF
ELEVATED SERUM TOTAL & LOW-DENSITY LIPOPROTEIN CHOLESTREROL IN
PATIENTS W/HYPERCHOLESTEROL IN PATIENTS W/HYPERCHOLESTEROLEMIA.
================== Physical/Chemical Properties ==================
Solubility in Water:INSOLUBLE
Appearance and Odor:ODORLESS GRANULES
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:LIGHT
Hazardous Decomposition Products:CO, CO2, HYDROCHLORIC ACID FUMES.
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|
|